AbbVie Debt Ratio from 2010 to 2025

ABBV Stock

USD 210.01 1.95 0.92%

AbbVie Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0.42 in 2025. During the period from 2010 to 2025, AbbVie Debt Ratio regression line of quarterly data had mean square error of 0.04 and geometric mean of 0.28. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.49677052

Current Value

0.42

Quarterly Volatility

0.20346543

Credit Downgrade

Yuan Drop

Covid

Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.

Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of AbbVie Inc over the last few years. It is AbbVie's Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

AbbVie Debt Ratio Regression Statistics

	Arithmetic Mean	0.48
	Geometric Mean	0.28
	Coefficient Of Variation	42.54
	Mean Deviation	0.13
	Median	0.53
	Standard Deviation	0.20
	Sample Variance	0.04
	Range	0.7463
	R-Value	0.38
	Mean Square Error	0.04
	R-Squared	0.15
	Significance	0.14
	Slope	0.02
	Total Sum of Squares	0.62

AbbVie Debt Ratio History

	2025	0.42
	2023	0.44
	2022	0.46
	2021	0.52
	2020	0.57
	2019	0.75
	2018	0.68

Other Fundumenentals of AbbVie Inc

Cash Flow To Debt Ratio

AbbVie Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Intangible Assets	Property Plant Equipment	Long Term Debt	Short Term Debt	Common Stock	Net Tangible Assets	Retained Earnings	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Treasury Stock	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Current Deferred Revenue
Total Assets		0.29	0.96	0.93	0.93	0.99	-0.42	0.99	0.65	0.97	0.96	0.94	0.79	-0.57	-0.96	-0.18	0.95	0.87	0.43	-0.01	-0.11	0.64	0.88	-0.39	-0.18	0.3
Total Stockholder Equity	0.29		0.23	0.24	0.36	0.32	-0.22	0.14	-0.25	0.42	0.37	0.03	0.18	0.28	-0.26	0.03	0.08	-0.03	0.07	-0.26	0.74	0.33	0.48	-0.43	0.14	-0.14
Net Debt	0.96	0.23		0.86	0.86	0.96	-0.32	0.96	0.52	0.98	0.93	0.93	0.8	-0.58	-0.96	-0.18	0.92	0.85	0.52	0.09	-0.12	0.65	0.85	-0.47	-0.18	0.31
Accounts Payable	0.93	0.24	0.86		0.96	0.95	-0.43	0.92	0.6	0.88	0.91	0.82	0.73	-0.62	-0.89	-0.25	0.84	0.88	0.42	0.0	-0.11	0.56	0.73	-0.48	-0.19	0.32
Net Receivables	0.93	0.36	0.86	0.96		0.96	-0.41	0.91	0.55	0.9	0.96	0.8	0.7	-0.48	-0.88	-0.33	0.83	0.8	0.26	-0.15	0.06	0.61	0.82	-0.54	-0.24	0.39
Good Will	0.99	0.32	0.96	0.95	0.96		-0.41	0.97	0.56	0.97	0.98	0.89	0.77	-0.53	-0.95	-0.26	0.91	0.87	0.44	0.0	-0.07	0.63	0.85	-0.51	-0.22	0.38
Short Term Investments	-0.42	-0.22	-0.32	-0.43	-0.41	-0.41		-0.4	-0.37	-0.38	-0.45	-0.35	-0.44	0.45	0.41	0.25	-0.48	-0.46	-0.02	0.35	0.0	-0.34	-0.46	0.11	0.21	-0.21
Total Liab	0.99	0.14	0.96	0.92	0.91	0.97	-0.4		0.72	0.94	0.93	0.97	0.78	-0.63	-0.95	-0.18	0.97	0.9	0.44	0.03	-0.24	0.61	0.83	-0.33	-0.19	0.32
Total Current Assets	0.65	-0.25	0.52	0.6	0.55	0.56	-0.37	0.72		0.48	0.51	0.77	0.46	-0.55	-0.57	0.02	0.75	0.63	0.13	-0.12	-0.5	0.31	0.52	0.3	-0.09	0.12
Intangible Assets	0.97	0.42	0.98	0.88	0.9	0.97	-0.38	0.94	0.48		0.95	0.89	0.79	-0.5	-0.96	-0.16	0.89	0.81	0.49	0.02	0.01	0.67	0.9	-0.51	-0.15	0.26
Property Plant Equipment	0.96	0.37	0.93	0.91	0.96	0.98	-0.45	0.93	0.51	0.95		0.84	0.77	-0.45	-0.91	-0.34	0.89	0.81	0.3	-0.15	0.07	0.68	0.87	-0.54	-0.22	0.43
Long Term Debt	0.94	0.03	0.93	0.82	0.8	0.89	-0.35	0.97	0.77	0.89	0.84		0.71	-0.65	-0.92	-0.1	0.97	0.86	0.48	0.03	-0.33	0.53	0.81	-0.18	-0.18	0.26
Short Term Debt	0.79	0.18	0.8	0.73	0.7	0.77	-0.44	0.78	0.46	0.79	0.77	0.71		-0.5	-0.8	-0.17	0.75	0.74	0.2	0.05	-0.09	0.91	0.73	-0.44	-0.15	0.21
Common Stock	-0.57	0.28	-0.58	-0.62	-0.48	-0.53	0.45	-0.63	-0.55	-0.5	-0.45	-0.65	-0.5		0.58	0.04	-0.61	-0.76	-0.51	-0.29	0.42	-0.21	-0.35	0.14	0.17	-0.17
Net Tangible Assets	-0.96	-0.26	-0.96	-0.89	-0.88	-0.95	0.41	-0.95	-0.57	-0.96	-0.91	-0.92	-0.8	0.58		0.24	-0.92	-0.86	-0.49	-0.06	0.14	-0.66	-0.88	0.49	0.32	-0.31
Retained Earnings	-0.18	0.03	-0.18	-0.25	-0.33	-0.26	0.25	-0.18	0.02	-0.16	-0.34	-0.1	-0.17	0.04	0.24		-0.23	-0.23	0.04	0.32	-0.29	-0.22	-0.28	0.62	0.84	-0.86
Long Term Debt Total	0.95	0.08	0.92	0.84	0.83	0.91	-0.48	0.97	0.75	0.89	0.89	0.97	0.75	-0.61	-0.92	-0.23		0.89	0.41	-0.06	-0.25	0.56	0.85	-0.24	-0.25	0.35
Capital Surpluse	0.87	-0.03	0.85	0.88	0.8	0.87	-0.46	0.9	0.63	0.81	0.81	0.86	0.74	-0.76	-0.86	-0.23	0.89		0.52	0.18	-0.35	0.45	0.64	-0.35	-0.28	0.4
Deferred Long Term Liab	0.43	0.07	0.52	0.42	0.26	0.44	-0.02	0.44	0.13	0.49	0.3	0.48	0.2	-0.51	-0.49	0.04	0.41	0.52		0.43	-0.21	-0.07	0.28	-0.22	-0.12	0.1
Long Term Investments	-0.01	-0.26	0.09	0.0	-0.15	0.0	0.35	0.03	-0.12	0.02	-0.15	0.03	0.05	-0.29	-0.06	0.32	-0.06	0.18	0.43		-0.48	-0.11	-0.3	-0.04	0.05	-0.09
Treasury Stock	-0.11	0.74	-0.12	-0.11	0.06	-0.07	0.0	-0.24	-0.5	0.01	0.07	-0.33	-0.09	0.42	0.14	-0.29	-0.25	-0.35	-0.21	-0.48		0.15	0.21	-0.46	-0.04	0.05
Short Long Term Debt	0.64	0.33	0.65	0.56	0.61	0.63	-0.34	0.61	0.31	0.67	0.68	0.53	0.91	-0.21	-0.66	-0.22	0.56	0.45	-0.07	-0.11	0.15		0.7	-0.49	-0.15	0.18
Net Invested Capital	0.88	0.48	0.85	0.73	0.82	0.85	-0.46	0.83	0.52	0.9	0.87	0.81	0.73	-0.35	-0.88	-0.28	0.85	0.64	0.28	-0.3	0.21	0.7		-0.42	-0.28	0.26
Net Working Capital	-0.39	-0.43	-0.47	-0.48	-0.54	-0.51	0.11	-0.33	0.3	-0.51	-0.54	-0.18	-0.44	0.14	0.49	0.62	-0.24	-0.35	-0.22	-0.04	-0.46	-0.49	-0.42		0.5	-0.51
Capital Stock	-0.18	0.14	-0.18	-0.19	-0.24	-0.22	0.21	-0.19	-0.09	-0.15	-0.22	-0.18	-0.15	0.17	0.32	0.84	-0.25	-0.28	-0.12	0.05	-0.04	-0.15	-0.28	0.5		-0.8
Current Deferred Revenue	0.3	-0.14	0.31	0.32	0.39	0.38	-0.21	0.32	0.12	0.26	0.43	0.26	0.21	-0.17	-0.31	-0.86	0.35	0.4	0.1	-0.09	0.05	0.18	0.26	-0.51	-0.8

Click cells to compare fundamentals

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Debt Ratio	0.50	0.42
Cash Flow To Debt Ratio	0.28	0.27

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AbbVie Debt Ratio from 2010 to 2025

Latest AbbVie's Debt Ratio Growth Pattern

AbbVie Debt Ratio Regression Statistics

AbbVie Debt Ratio History

Other Fundumenentals of AbbVie Inc

AbbVie Debt Ratio component correlations

About AbbVie Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for AbbVie Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY